In 1969 was created Janus Capital Group, which is appeared as VC. The company was established in North America in United States. The leading representative office of defined VC is situated in the Denver.
Among the most popular portfolio startups of the fund, we may highlight Lyft, AveXis, Workday. We can highlight the next thriving fund investment areas, such as SaaS, Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups.
The usual things for fund are deals in the range of more than 100 millions dollars. When the investment is from Janus Capital Group the average startup value is more than 1 billion dollars. The high activity for fund was in 2015. This Janus Capital Group works on 47 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Janus Capital Group, startups are often financed by Greylock Partners, Andreessen Horowitz, Shasta Ventures. The meaningful sponsors for the fund in investment in the same round are Foresite Capital, T. Rowe Price, RA Capital Management. In the next rounds fund is usually obtained by SharesPost Investment Management, M13, UTA Ventures.
The overall number of key employees were 10.
Related Funds
Funds with similar focus
Fund Name | Location |
54 Madison Partners | New York, New York, United States |
Agility Ventures | Haryana, Haryana, India |
Allied Architects | Chiyoda, Japan |
APEC | Hsinchu, Taiwan, Taiwan Province |
Ground Squirrel Ventures | Boston, Massachusetts, United States |
Growth Capital Ventures | England, London, United Kingdom |
LITTLEROCK | Düsseldorf, Germany, Nordrhein-Westfalen |
Mica Ventures | - |
Nelstone Ventures | New York, New York, United States |
Product Trust Investments | - |
SCB 10X | Bangkok, Krung Thep, Thailand |
SmartAngels.fr | France, Ile-de-France, Paris |
Tracker Capital Management | New York, New York, United States |
Triangle Venture Alliance | - |
Triax Capital | New York, New York, United States |
UCHealth | Cincinnati, Ohio, United States |
VIKO GROUP | Barcelona, Catalonia, Spain |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Bigfoot Biomedical | $18M | 21 Mar 2018 | Milpitas, California, United States | ||
Silk Road Medical | $47M | 18 Jul 2017 | Sunnyvale, California, United States | ||
Solid Biosciences | $50M | 30 Mar 2017 | Marlborough, Massachusetts, United States | ||
Intellia Therapeutics | $70M | 01 Sep 2015 | Cambridge, Massachusetts, United States | ||
Edge Therapeutics | $56M | 09 Apr 2015 | New Jersey, United States | ||
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
MediQuest Therapeutics | $16M | 15 Jun 2006 | Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Bigfoot Biomedical | $18M | 21 Mar 2018 | Milpitas, California, United States | ||
Silk Road Medical | $47M | 18 Jul 2017 | Sunnyvale, California, United States | ||
Solid Biosciences | $50M | 30 Mar 2017 | Marlborough, Massachusetts, United States | ||
Intellia Therapeutics | $70M | 01 Sep 2015 | Cambridge, Massachusetts, United States | ||
Edge Therapeutics | $56M | 09 Apr 2015 | New Jersey, United States | ||
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
MediQuest Therapeutics | $16M | 15 Jun 2006 | Washington, United States |